Sangamo Therapeutics, Inc. (SGMO)

NASDAQ: SGMO · IEX Real-Time Price · USD

0.512

+0.026 (5.44%)

At close: Apr 19, 2024, 4:00 PM

0.519

+0.008 (1.54%)

After-hours: Apr 19, 2024, 7:22 PM EDT

Sangamo Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1997
Net Income	-257.83	-192.28	-178.29	-121	-95.19	-68.33	-54.57	-71.66	-40.7	-26.42	Upgrade
Depreciation & Amortization	22.19	20.56	17.64	13.37	9.61	2.36	1.5	1	0.99	0.55	Upgrade
Share-Based Compensation	27.36	31.65	32.96	25.71	19.33	14.68	9.09	15.06	11.73	9.2	Upgrade
Other Operating Activities	-16.57	-83.56	-105.56	251.79	-78.15	87.85	55.16	-10.28	-5.74	10.99	Upgrade
Operating Cash Flow	-224.84	-223.63	-233.25	169.88	-144.4	36.55	11.18	-65.88	-33.72	-5.68	Upgrade
Operating Cash Flow Growth	-	-	-	-	-	226.95%	-	-	-	-	Upgrade
Capital Expenditures	-21.16	-20.17	-23.28	-14.71	-20.68	-43.07	-3.75	-0.73	0	0	Upgrade
Acquisitions	0	0	-0.12	-0.7	-0.26	-75.65	0	0	-2.41	-0.62	Upgrade
Change in Investments	174.69	79.46	271.6	-256.21	-38.86	-59.39	-73.65	18.86	79.87	-100.04	Upgrade
Investing Cash Flow	153.53	59.29	248.2	-271.63	-59.8	-178.11	-77.4	18.13	77.46	-100.66	Upgrade
Share Issuance / Repurchase	16.04	86.76	36.12	153.87	142.45	231.96	98.14	1.11	6.8	106.73	Upgrade
Other Financing Activities	-1.45	-2.1	-3.26	-0.77	-0.42	-0.25	-0.65	-0.78	12.91	-4.56	Upgrade
Financing Cash Flow	14.59	84.66	32.86	153.1	142.03	231.71	97.49	0.34	19.71	102.18	Upgrade
Exchange Rate Effect	1.48	1.25	-0.26	-0.45	0.18	0.44	0	0	0	0	Upgrade
Net Cash Flow	-55.24	-78.43	47.54	50.9	-61.99	90.59	31.27	-47.42	63.45	-4.16	Upgrade
Free Cash Flow	-246	-243.8	-256.53	155.16	-165.08	-6.52	7.43	-66.62	-33.72	-5.68	Upgrade
Free Cash Flow Margin	-139.59%	-219.05%	-231.73%	131.28%	-161.16%	-7.71%	20.31%	-343.57%	-85.28%	-12.37%	Upgrade
Free Cash Flow Per Share	-1.41	-1.58	-1.77	1.15	-1.47	-0.07	0.10	-0.94	-0.48	-0.09	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).